CHONGQING ZHENGCHUAN PHARMACEUTICAL PACKAGING CO.,LTD

Cash flow ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd

Stocks

603976

CNE100002W50

Non-Paper Containers & Packaging

End-of-day quote Shanghai S.E. Other stock markets 20/07/2026			5-day change	1st Jan Change
22.48 ^CNY	-10.01%		-10.26%	+16.30%

05-23	Beijing Anjing Licheng Health Technology Partnership Enterprise (Limited Partnership) signed a Share Transfer Agreement to acquire 10% stake in ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd from Chongqing Zhengchuan Investment Management Co., Ltd. for approximately CNY 270 million.	CI
04-26	ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd announces Annual dividend, payable on May 28, 2026	CI

d8.IW5QuXdi3-OxWvVhFJQkh1duW0Cc2eZ2VcqfLV_t-ps.UjoDzTtXubmCI7cLTqRvvgFaazjd4Lw-ILnTST7fjPZiJinOHQSFjtZ3ng

Published financial data: CHONGQING ZHENGCHUAN PHARMACEUTICAL PACKAGING CO.,LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	794M	793M	897M	798M	662M
Other Revenues, Total	3.04M	3.19M	3.74M	3.33M	2.12M
Total Revenues	797M	796M	901M	801M	664M
Cost of Goods Sold, Total	598M	643M	759M	654M	556M
Gross Profit	198M	153M	142M	147M	108M
Selling General & Admin Expenses, Total	58.93M	57.45M	57.13M	57.53M	55.36M
Provision for Bad Debts	1.89M	630K	877K	-288K	2.97M
R&D Expenses	12.08M	19.11M	23.43M	20.26M	14.51M
Other Operating Expenses	9.22M	9.54M	9.32M	24.33K	8.86M
Other Operating Expenses, Total	82.11M	86.74M	90.76M	77.52M	81.69M
Operating Income	116M	66.51M	50.87M	69.67M	26.26M
Interest Expense, Total	-13.08M	-19.61M	-21.26M	-20.95M	-21.31M
Interest And Investment Income	9.12M	8.39M	9.17M	9.8M	8.7M
Net Interest Expenses	-3.96M	-11.21M	-12.09M	-11.15M	-12.61M
Currency Exchange Gains (Loss)	733K	-59.58K	-250K	73.49K	277K
Other Non Operating Income (Expenses)	401K	-111K	-36.94K	-43.2K	-57.18K
EBT, Excl. Unusual Items	113M	55.13M	38.49M	58.56M	13.87M
Gain (Loss) On Sale Of Investments	4.76M	-941K	1.05M	468K	-50K
Gain (Loss) On Sale Of Assets	32.21K	-1.32M	-189K	-5.3M	-832K
Asset Writedown	-563K	-	-	-	-
Legal Settlements	-1.87M	-13.33K	-	-	-
Other Unusual Items	10.2M	5.7M	5.47M	6.49M	7.05M
EBT, Incl. Unusual Items	126M	58.55M	44.83M	60.21M	20.04M
Income Tax Expense	19.37M	-6.21M	4.56M	6.96M	1.14M
Earnings From Continuing Operations	107M	64.77M	40.27M	53.25M	18.9M
Net Income to Company	107M	64.77M	40.27M	53.25M	18.9M
Net Income - (IS)	107M	64.77M	40.27M	53.25M	18.9M
Net Income to Common Incl Extra Items	107M	64.77M	40.27M	53.25M	18.9M
Net Income to Common Excl. Extra Items	107M	64.77M	40.27M	53.25M	18.9M
Per Share Items
Net EPS - Basic	0.71	0.43	0.27	0.35	0.13
Basic EPS - Continuing Operations	0.71	0.43	0.27	0.35	0.13
Basic Weighted Average Shares Outstanding	150M	151M	149M	152M	145M
Net EPS - Diluted	0.71	0.43	0.27	0.35	0.13
Diluted EPS - Continuing Operations	0.71	0.43	0.27	0.35	0.13
Diluted Weighted Average Shares Outstanding	150M	151M	149M	152M	145M
Normalized Basic EPS	0.47	0.23	0.16	0.24	0.06
Normalized Diluted EPS	0.47	0.23	0.16	0.24	0.06
Dividend Per Share	0.31	0.06	0.2	0.35	0.29
Payout Ratio	5.82	76.66	33.09	95.17	235.32
Supplemental Items
EBITDA	182M	152M	156M	184M	133M
EBITA	117M	67.56M	51.93M	70.7M	27.31M
EBIT	116M	66.51M	50.87M	69.67M	26.26M
EBITDAR	183M	153M	157M	185M	134M
Total Revenues (As Reported)	797M	796M	901M	801M	664M
Effective Tax Rate - (Ratio)	15.38	-10.61	10.17	11.56	5.68
Total Current Taxes	24.39M	-13.96M	3.97M	3.13M	1.66M
Total Deferred Taxes	-5.02M	7.74M	586K	3.83M	-521K
Normalized Net Income	70.89M	34.45M	24.06M	36.6M	8.67M
Interest on Long-Term Debt	12.35M	19.05M	19.84M	20.61M	21.31M
Supplemental Operating Expense Items
Advertising Expense	2.02M	605K	384K	-	1.22M
Selling and Marketing Expenses	17.97M	15.13M	13.61M	14.43M	18.09M
General and Administrative Expenses	40.96M	42.32M	43.53M	43.09M	37.26M
Research And Development Expense From Footnotes	34.49M	19.11M	23.43M	20.26M	14.51M
Net Rental Expense, Total	1.02M	1.05M	1.06M	1.03M	1.05M
Imputed Operating Lease Interest Expense	441K	367K	399K	393K	406K
Imputed Operating Lease Depreciation	578K	679K	664K	637K	640K
Maintenance & Repair Expenses, Total	-	-	-	-	1.37M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	392M	212M	188M	109M	325M
Short Term Investments	-	-	-	-	157M
Trading Asset Securities, Total	255M	159M	250M	141M	-
Total Cash And Short Term Investments	647M	371M	438M	249M	482M
Accounts Receivable, Total	298M	356M	398M	365M	339M
Other Receivables	2.86M	20.26M	5.51M	4.15M	4.29M
Total Receivables	301M	376M	403M	369M	343M
Inventory	191M	209M	197M	250M	230M
Other Current Assets, Total	12.45M	35.03M	12.87M	7.17M	8.45M
Total Current Assets	1.15B	992M	1.05B	876M	1.06B
Gross Property Plant And Equipment	989M	1.3B	1.41B	1.42B	1.43B
Accumulated Depreciation	-323M	-387M	-486M	-563M	-646M
Net Property Plant And Equipment	666M	910M	919M	860M	782M
Long-term Investments	50K	50K	50K	50K	-
Other Intangibles, Total	42.98M	41.6M	40.41M	39.36M	38.31M
Deferred Tax Assets Long-Term	5.89M	1.12M	12.65M	8.82M	9.34M
Deferred Charges Long-Term	4.27M	3.9M	2.74M	2.23M	1.64M
Other Long-Term Assets, Total	90.33M	59.41M	16.38M	171M	6.66M
Total Assets	1.96B	2.01B	2.04B	1.96B	1.9B
Liabilities
Accounts Payable, Total	278M	297M	314M	240M	192M
Accrued Expenses, Total	26.4M	20.68M	23.82M	22.81M	25.58M
Short-term Borrowings	50M	60M	30M	-	-
Current Portion of Leases	320K	370K	200K	57.98K	57.78K
Current Income Taxes Payable	13.28M	980K	3.3M	923K	1.45M
Unearned Revenue Current, Total	6.76M	6.77M	4.61M	3.39M	4.19M
Other Current Liabilities	3.06M	4.22M	3.63M	2.43M	2.06M
Total Current Liabilities	378M	390M	379M	270M	225M
Long-Term Debt	382M	399M	416M	432M	446M
Long-Term Leases	906K	535K	64.35K	33.92K	11.49K
Unearned Revenue Non Current	30.72M	28.63M	31.61M	31.3M	25.3M
Deferred Tax Liability Non Current	2.4M	5.37M	-	-	-
Total Liabilities	795M	823M	827M	733M	696M
Common Stock, Total	151M	151M	151M	151M	151M
Additional Paid In Capital	556M	556M	556M	556M	556M
Retained Earnings	435M	453M	484M	492M	474M
Comprehensive Income and Other	24.35M	24.35M	24.35M	24.35M	24.34M
Total Common Equity	1.17B	1.18B	1.22B	1.22B	1.21B
Total Equity	1.17B	1.18B	1.22B	1.22B	1.21B
Total Liabilities And Equity	1.96B	2.01B	2.04B	1.96B	1.9B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	151M	151M	151M	151M	151M
ECS Total Common Shares Outstanding	151M	151M	151M	151M	151M
Book Value / Share	7.71	7.83	8.04	8.09	7.97
Tangible Book Value	1.12B	1.14B	1.18B	1.18B	1.17B
Tangible Book Value Per Share	7.43	7.56	7.77	7.83	7.72
Total Debt	434M	460M	447M	432M	446M
Net Debt	-213M	88.68M	8.78M	183M	-35.66M
Debt Equivalent Oper. Leases	8.15M	8.37M	8.5M	8.24M	8.37M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	51.34M	75.16M	52.51M	50.42M	49.01M
Inventories - Work In Process, Total	27.16M	19.62M	19.86M	33.25M	41.53M
Inventories - Finished Goods, Total	119M	132M	137M	191M	167M
Buildings, Total	359M	363M	468M	467M	459M
Machinery, Total	608M	734M	927M	903M	933M
Full Time Employees	1.76K	1.79K	1.78K	1.65K	1.36K
Accumulated Allowance for Doubtful Accounts (Supple)	10.56M	11.1M	11.87M	11.62M	14.74M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	107M	64.77M	40.27M	53.25M	18.9M
Depreciation & Amortization - CF	65.35M	85.08M	104M	114M	106M
Amortization of Goodwill and Intangible Assets - (CF)	1.02M	1.05M	1.06M	1.03M	1.05M
Depreciation & Amortization, Total	66.37M	86.13M	106M	115M	107M
Amortization of Deferred Charges, Total - (CF)	1.95M	1.72M	1.78M	1.54M	947K
(Gain) Loss From Sale Of Asset	-32.21K	-	17.46K	-	-
(Gain) Loss on Sale of Investments - (CF)	-6.06M	-2.57M	-6.96M	-3.47M	-2.98M
Asset Writedown & Restructuring Costs	8.74M	1.32M	172K	5.3M	832K
Provision and Write-off of Bad Debts	-	630K	877K	-288K	2.97M
Other Operating Activities, Total	13.08M	33.47M	23.37M	37.03M	28.65M
Change In Accounts Receivable	-188M	-110M	-57.43M	22.41M	2.32M
Change In Inventories	-45.52M	-32.47M	10.15M	-71.79M	8.06M
Change In Accounts Payable	153M	-12.67M	93.27M	-50.22M	-29.38M
Change In Deferred Taxes	-5.02M	7.74M	-16.89M	3.83M	-521K
Cash from Operations	105M	38.43M	194M	112M	136M
Capital Expenditure	-138M	-276M	-89.97M	-71.98M	-27.09M
Sale of Property, Plant, and Equipment	152K	-	40.99K	154K	27.82K
Investment in Marketable and Equity Securities, Total	-249M	90M	-90M	-37M	143M
Other Investing Activities, Total	205K	17.06M	3.18M	-3.51M	8.49M
Cash from Investing	-386M	-169M	-177M	-112M	124M
Short Term Debt Issued, Total	50M	60M	60M	-	-
Total Debt Issued	50M	60M	60M	-	-
Short Term Debt Repaid, Total	-49.7M	-50M	-90M	-30M	-
Long-Term Debt Repaid, Total	-388K	-276K	-320K	-212K	-236K
Total Debt Repaid	-50.09M	-50.28M	-90.32M	-30.21M	-236K
Issuance of Common Stock	405M	-	-	-	-
Common Dividends Paid	-6.2M	-49.65M	-13.33M	-50.68M	-44.48M
Common & Preferred Stock Dividends Paid	-6.2M	-49.65M	-13.33M	-50.68M	-44.48M
Other Financing Activities, Total	-11.61M	6.02M	-	-	-
Cash from Financing	387M	-33.91M	-43.64M	-80.89M	-44.72M
Foreign Exchange Rate Adjustments	-9.4K	164K	19.45K	-25.83K	183K
Net Change in Cash	106M	-164M	-26.18M	-81.07M	216M
Supplemental Items
Cash Income Tax Paid (Refund)	46.29M	50.4M	39.77M	39.46M	39.67M
Levered Free Cash Flow	-14.59M	-274M	62.65M	-17.57M	83.33M
Unlevered Free Cash Flow	-6.42M	-261M	75.94M	-4.47M	96.65M
Change In Net Working Capital	9.85M	115M	-26.77M	92.17M	289K
Net Debt Issued / Repaid	-88.05K	9.72M	-30.32M	-30.21M	-236K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.42	2.1	1.57	2.18	0.85
Return on Total Capital	5.4	2.56	1.92	2.63	0.99
Return On Equity %	9.66	5.51	3.36	4.37	1.56
Return on Common Equity	9.66	5.51	3.36	4.37	1.56
Margin Analysis
Gross Profit Margin %	24.9	19.25	15.72	18.37	16.25
SG&A Margin	7.4	7.22	6.34	7.18	8.33
EBITDA Margin %	22.88	19.13	17.34	22.97	19.97
EBITA Margin %	14.72	8.48	5.77	8.83	4.11
EBIT Margin %	14.59	8.35	5.65	8.7	3.95
Income From Continuing Operations Margin %	13.38	8.13	4.47	6.65	2.85
Net Income Margin %	13.38	8.13	4.47	6.65	2.85
Net Avail. For Common Margin %	13.38	8.13	4.47	6.65	2.85
Normalized Net Income Margin	8.9	4.33	2.67	4.57	1.3
Levered Free Cash Flow Margin	-1.83	-34.36	6.96	-2.19	12.54
Unlevered Free Cash Flow Margin	-0.81	-32.82	8.43	-0.56	14.55
Asset Turnover
Asset Turnover	0.49	0.4	0.44	0.4	0.34
Fixed Assets Turnover	1.31	1.01	0.98	0.9	0.81
Receivables Turnover (Average Receivables)	3.03	2.43	2.38	2.09	1.88
Inventory Turnover (Average Inventory)	3.5	3.22	3.73	2.92	2.31
Short Term Liquidity
Current Ratio	3.04	2.55	2.77	3.24	4.72
Quick Ratio	2.51	1.92	2.22	2.29	3.66
Operating Cash Flow to Current Liabilities	0.28	0.1	0.51	0.42	0.61
Days Sales Outstanding (Average Receivables)	120.59	150.49	153.31	174.9	193.77
Days Outstanding Inventory (Average Inventory)	104.25	113.52	97.76	125.27	157.72
Average Days Payable Outstanding	136.2	158.55	149.21	143.43	147.09
Cash Conversion Cycle (Average Days)	88.64	105.45	101.85	156.73	204.4
Long Term Solvency
Total Debt/Equity	37.18	38.86	36.73	35.32	37.01
Total Debt / Total Capital	27.1	27.98	26.87	26.1	27.01
LT Debt/Equity	32.87	33.76	34.25	35.31	37
Long-Term Debt / Total Capital	23.96	24.31	25.05	26.1	27.01
Total Liabilities / Total Assets	40.53	41.02	40.5	37.48	36.62
EBIT / Interest Expense	8.89	3.39	2.39	3.33	1.23
EBITDA / Interest Expense	13.96	7.78	7.36	8.8	6.24
(EBITDA - Capex) / Interest Expense	3.45	-6.3	3.13	5.36	4.97
Total Debt / EBITDA	2.37	3.01	2.85	2.34	3.36
Net Debt / EBITDA	-1.17	0.58	0.06	0.99	-0.27
Total Debt / (EBITDA - Capex)	9.62	-3.73	6.72	3.85	4.21
Net Debt / (EBITDA - Capex)	-4.73	-0.72	0.13	1.63	-0.34
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	58.7	-0.06	13.12	-11.05	-17.07
Gross Profit, 1 Yr. Growth %	85.82	-22.74	-7.58	3.93	-25.64
EBITDA, 1 Yr. Growth %	85.95	-16.78	2.33	17.75	-27.92
EBITA, 1 Yr. Growth %	155.14	-42.74	-23.51	35.8	-61.39
EBIT, 1 Yr. Growth %	161.1	-42.93	-23.52	36.96	-62.31
Earnings From Cont. Operations, 1 Yr. Growth %	100.95	-39.25	-37.83	32.24	-64.5
Net Income, 1 Yr. Growth %	100.95	-39.25	-37.83	32.24	-64.5
Normalized Net Income, 1 Yr. Growth %	106.81	-51.37	-30.27	52.12	-76.31
Diluted EPS Before Extra, 1 Yr. Growth %	102.86	-39.44	-37.21	29.63	-62.86
Accounts Receivable, 1 Yr. Growth %	31.99	19.16	11.92	-8.38	-7.13
Inventory, 1 Yr. Growth %	25.93	9.93	-5.87	27.06	-8.02
Net Property, Plant and Equip., 1 Yr. Growth %	20.43	36.64	1.06	-6.51	-9.01
Total Assets, 1 Yr. Growth %	48.01	2.41	1.75	-4.21	-2.82
Tangible Book Value, 1 Yr. Growth %	12.46	1.75	2.84	0.76	-1.45
Common Equity, 1 Yr. Growth %	12.07	1.56	2.64	0.65	-1.49
Cash From Operations, 1 Yr. Growth %	-13.82	-63.39	405.37	-42.23	21.65
Capital Expenditures, 1 Yr. Growth %	-21.8	100.72	-67.41	-20	-62.36
Levered Free Cash Flow, 1 Yr. Growth %	-79.12	1.8K	-122.9	-128.04	-574.35
Unlevered Free Cash Flow, 1 Yr. Growth %	-90.79	4.09K	-129.06	-105.89	-2.26K
Dividend Per Share, 1 Yr. Growth %	755.56	-80.52	233.33	73	-16.18
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	23.65	25.94	6.33	0.31	-14.11
Gross Profit, 2 Yr. CAGR %	18.68	19.82	-15.5	-1.99	-12.69
EBITDA, 2 Yr. CAGR %	30.53	24.65	-7.62	9.81	-7.87
EBITA, 2 Yr. CAGR %	43.55	21.24	-33.65	2.04	-27.58
EBIT, 2 Yr. CAGR %	44.58	22.23	-33.93	2.34	-28.15
Earnings From Cont. Operations, 2 Yr. CAGR %	32.14	10.49	-38.54	-9.33	-31.48
Net Income, 2 Yr. CAGR %	32.14	10.49	-38.54	-9.33	-31.48
Normalized Net Income, 2 Yr. CAGR %	28.66	0.26	-41.73	3	-39.97
Diluted EPS Before Extra, 2 Yr. CAGR %	33.23	10.84	-38.33	-9.78	-30.61
Accounts Receivable, 2 Yr. CAGR %	12.79	25.41	15.48	1.26	-7.75
Inventory, 2 Yr. CAGR %	14.36	17.66	1.73	9.36	8.11
Net Property, Plant and Equip., 2 Yr. CAGR %	29.99	28.28	17.51	-2.8	-7.77
Total Assets, 2 Yr. CAGR %	25.69	23.11	2.08	-1.27	-3.52
Tangible Book Value, 2 Yr. CAGR %	6.34	6.97	2.29	1.8	-0.35
Common Equity, 2 Yr. CAGR %	6.09	6.69	2.1	1.64	-0.43
Cash From Operations, 2 Yr. CAGR %	37.81	-43.83	36.02	70.86	-16.17
Capital Expenditures, 2 Yr. CAGR %	10.99	25.29	-19.12	-48.94	-45.13
Levered Free Cash Flow, 2 Yr. CAGR %	152.23	97.83	108.51	-74.66	15.33
Unlevered Free Cash Flow, 2 Yr. CAGR %	67.3	93.59	248.93	-86.92	12.82
Dividend Per Share, 2 Yr. CAGR %	-2.5	29.1	-19.42	140.14	20.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.17	15.18	21.51	0.19	-5.86
Gross Profit, 3 Yr. CAGR %	5.15	2.85	9.88	-9.46	-11.02
EBITDA, 3 Yr. CAGR %	12.53	12.49	16.8	0.19	-4.56
EBITA, 3 Yr. CAGR %	13.27	5.89	4.16	-15.69	-26.19
EBIT, 3 Yr. CAGR %	13.44	6.15	4.55	-15.76	-26.64
Earnings From Cont. Operations, 3 Yr. CAGR %	8.8	1.98	-8.78	-20.66	-33.67
Net Income, 3 Yr. CAGR %	8.8	1.98	-8.78	-20.66	-33.67
Normalized Net Income, 3 Yr. CAGR %	6.85	-6.99	-11.13	-19.77	-36.9
Diluted EPS Before Extra, 3 Yr. CAGR %	8.88	2.44	-8.29	-21	-32.88
Accounts Receivable, 3 Yr. CAGR %	10.64	14.87	20.74	6.91	-1.61
Inventory, 3 Yr. CAGR %	17.3	12.87	9.23	9.55	3.23
Net Property, Plant and Equip., 3 Yr. CAGR %	25.13	32.17	18.48	8.89	-4.91
Total Assets, 3 Yr. CAGR %	20.29	17.39	15.54	-0.06	-1.79
Tangible Book Value, 3 Yr. CAGR %	5.99	4.79	5.58	1.78	0.7
Common Equity, 3 Yr. CAGR %	5.71	4.56	5.32	1.62	0.59
Cash From Operations, 3 Yr. CAGR %	17.75	-11.41	16.83	2.24	52.57
Capital Expenditures, 3 Yr. CAGR %	25.74	35.23	-20.03	-19.42	-53.88
Levered Free Cash Flow, 3 Yr. CAGR %	121.21	392.22	-3.59	6.83	-32.72
Unlevered Free Cash Flow, 3 Yr. CAGR %	68.25	384.76	2.89	-10.49	-28.22
Dividend Per Share, 3 Yr. CAGR %	56.73	-43	77.11	3.95	69.08
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.13	9.37	8.62	8.98	5.77
Gross Profit, 5 Yr. CAGR %	6.21	-1	-3.66	0.89	0.22
EBITDA, 5 Yr. CAGR %	10.31	2.15	4.07	11.46	6.24
EBITA, 5 Yr. CAGR %	7.84	-6.74	-8.44	4.44	-9.89
EBIT, 5 Yr. CAGR %	7.83	-6.88	-8.57	4.61	-10.02
Earnings From Cont. Operations, 5 Yr. CAGR %	8.62	-4.65	-13.42	-2.7	-18.65
Net Income, 5 Yr. CAGR %	8.62	-4.65	-13.42	-2.7	-18.65
Normalized Net Income, 5 Yr. CAGR %	7.17	-10.79	-16.17	-3.09	-24.04
Diluted EPS Before Extra, 5 Yr. CAGR %	2.7	-7.93	-13.26	-2.64	-17.97
Accounts Receivable, 5 Yr. CAGR %	15.03	16.25	12.55	9.22	8.42
Inventory, 5 Yr. CAGR %	21.05	14.12	10.8	11.45	8.78
Net Property, Plant and Equip., 5 Yr. CAGR %	19.64	24.77	22.02	16.88	7.19
Total Assets, 5 Yr. CAGR %	25.85	13.59	12.64	9.54	7.5
Tangible Book Value, 5 Yr. CAGR %	18.34	4.35	4.5	3.58	3.16
Common Equity, 5 Yr. CAGR %	17.75	4.42	4.25	3.38	2.98
Cash From Operations, 5 Yr. CAGR %	32.48	-7.21	24.74	15.21	2.3
Capital Expenditures, 5 Yr. CAGR %	72.97	46.76	5.39	-8.41	-31.21
Levered Free Cash Flow, 5 Yr. CAGR %	-30.46	74.53	115.49	50.25	3.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	-41	72.61	123.94	14.29	6.75
Dividend Per Share, 5 Yr. CAGR %	6.14	-28.83	20.11	1.32	51.78